Suchergebnisse - "Ray-Coquard, Isabelle"

PubPharm (727)

1

Contraception in breast cancer survivors from the FEERIC case-control study (performed on behalf of the Seintinelles research network)

enthalten in: bioRxiv.org | 2024

von Sebbag, C. | Rousset-Jablonski, C. | Coussy, F. | +30

2

Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Boidot, R. | Blum, M. | Wissler, M. | +21

3

Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer

enthalten in: Leukemia | 2024

von Arends, C. | Kopp, K. | Hablesreiter, R. | +18

4

Mirvetuximab soravtansine-gynx : first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Bogani, G. | Coleman, R. | Vergote, I. | +8

5

Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2024

von Lorusso, D. | Mouret-Reynier, M. | Harter, P. | +27

6

Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations

enthalten in: JAMA network open | 2024

von Schouten, P. | Schmidt, S. | Becker, K. | +20

7

Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer : an International Cancer Benchmarking Partnership (ICBP) population-based study

enthalten in: The Lancet. Oncology | 2024

von McPhail, S. | Barclay, M. | Swann, R. | +54

8

Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer : an International Cancer Benchmarking Partnership (ICBP) population-based study

enthalten in: The Lancet. Oncology | 2024

von McPhail, S. | Barclay, M. | Johnson, S. | +57

9

Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer

enthalten in: Bulletin du cancer | 2024

von Harter, P. | Bogner, G. | Chiva, L. | +21

10

Management of patients with rare adult solid cancers : objectives and evaluation of European reference networks (ERN) EURACAN

enthalten in: The Lancet regional health. Europe | 2024

von Blay, J. | Casali, P. | Ray-Coquard, I. | +25

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[73]